Ching-yi Chang

Title: Ching-yi Chang: Innovator in Breast Cancer Treatment

Introduction

Ching-yi Chang is a prominent inventor based in Durham, NC (US). He has made significant contributions to the field of cancer treatment, particularly focusing on estrogen receptor positive breast cancer. With a total of 6 patents, his work has the potential to impact the lives of many women battling this disease.

Latest Patents

One of Ching-yi Chang's latest patents involves the use of lasofoxifene for the treatment of breast cancer. The disclosure provides methods for treating estrogen receptor positive (ER) cancer in women with an effective amount of lasofoxifene, a pharmaceutically acceptable salt thereof, or a prodrug thereof. Additionally, the patent includes the detection of the Estrogen Receptor 1 (ESR1) gene mutations that lead to endocrine resistance and treatment of endocrine resistant ER cancers.

Career Highlights

Ching-yi Chang is affiliated with Duke University, where he conducts his research and develops innovative treatments. His work is characterized by a commitment to advancing medical science and improving patient outcomes.

Collaborations

Ching-yi Chang collaborates with notable colleagues, including Kaitlyn Andreano and Donald P McDonnell. These partnerships enhance the research efforts and contribute to the development of effective cancer treatments.

Conclusion

Ching-yi Chang's contributions to breast cancer treatment through his innovative patents and collaborations highlight his dedication to improving healthcare. His work continues to pave the way for advancements in cancer therapy.